Dermata Therapeutics, Inc. Common Stock DRMA

$1.46 -7.01% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q 10-Q 2026-08-11 View →
8-K 8-K 2026-08-11 View →
8-K 8-K 2026-08-05 View →
4 4 2026-06-16 View →
8-K 8-K 2026-05-27 View →
10-Q 10-Q 2026-05-13 View →
8-K 8-K 2026-05-13 View →
DEF 14A DEF 14A 2026-04-17 View →
10-K 10-K 2026-03-26 View →
8-K 8-K 2026-03-26 View →
4 4 2026-03-17 View →
8-K 8-K 2026-02-25 View →
8-K 8-K 2026-02-03 View →
8-K 8-K 2026-01-27 View →
424B5 424B5 2026-01-27 View →
S-3 S-3 2026-01-22 View →
4 Insider transaction 2026-01-06 View →
4 Insider transaction 2026-01-06 View →
4 4 2026-01-06 View →
4 Insider transaction 2026-01-06 View →
4 4 2026-01-06 View →
4 Insider transaction 2026-01-06 View →
4 4 2026-01-06 View →
4 4 2026-01-06 View →
4 Insider transaction 2026-01-06 View →
4 4 2026-01-06 View →
4 4 2026-01-06 View →
4 Insider transaction 2025-12-29 View →
4 Insider transaction 2025-12-29 View →
8-K 8-K 2025-12-29 View →
S-3 S-3 2025-11-24 View →
8-K 8-K 2025-11-18 View →
10-Q 10-Q 2025-11-14 View →
8-K 8-K 2025-11-14 View →
8-K 8-K 2025-11-07 View →
424B5 424B5 2025-11-07 View →
8-K 8-K 2025-09-17 View →
8-K 8-K 2025-09-10 View →
8-K 8-K 2025-08-25 View →
10-Q 10-Q 2025-08-13 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$1.46
Market Cap
$5.87 million
52-Week Range
$0.95 – $8.00
Average Volume
1.44 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.